VASCULOPROTECTIVE PHARMACEUTICAL COMPOSITIONS CONTAINING A UBIQUINONE DERIVATIVE AND AT LEAST ONE OTHER COMPOUND HAVING A VASCULOPROTECTIVE ACTIVITY

摘要

PHARMACEUTICAL COMPOSITIONS HAVING VASCULOPROTECTIVE ACTIVITY CONTAINING A UBIQUINONE DERIVATIVE AND AT LEAST ONE OTHER COMPOUND HAVING KNOWN VASCULOPROTECTIVE ACTIVITY. PREFERABLY, THE UBIQUINONE DERIVATIVE IS COENZYME Q. / P P ADVANTAGEALLY, KNOWN COMPOUNDS HAVING VASCULOPROTECTIVE ACTIVITY ARE CHOSEN AMONG COMPOUNDS HAVING FLAVONOID, HEPARINOID, TERPENIC OR GLUCOSIDIC STRUCTURE, AND MORE PREFERABLY, IN THE GROUP COMPRISING: RUTIN, O- (B-HYDROXYETHYLRUTOSIDE), DELPHINIDINE, HESPERIDINE, DIOSMINE, ASIATICOSIDE, CATECHIN, HEPARIN, ESCIN, RUSCOGENINE, TRIBENOSIDE, SODIUM 2-PHENYL-5,7-DIOXYACETATE, BENZO-G-PYRONE. / P P COENZYME Q AND VASCULOPROTECTIVE COMPOUND MAY BE PRESENT IN REPORTS VARYING FROM 1: 1 TO 1: 1000. COMPOSITIONS ACCORDING TO THE INVENTION MAY BE ADMINISTERED ORAL, PARENTERAL, RECTAL OR TOPICAL, IN THE FORM OF CAPSULES, TABLETS, SYRUPS, PELLETS, STERILE SOLUTIONS, OINTMENTS, CREAMS, LOTIONS, GELS OR SUPPOSITORIES. / P OBSERVED, UNEXPECTEDLY, A SYNERGY OF THE THERAPEUTIC EFFECTS OF COMPONENTS WITHOUT AGGRAVATING THE TOXICITY.